Tandem Agreement Meaning

Tandem Agreement Meaning

Tandem Diabetes CareMedia:Steve Sabicer, 714-907-6264ssabicer@thesabicergroup.comorInvestors:Susan Morrison, 858-366-6900 x7005smorrison@tandemdiabetes.comorRubin MedicalEmina Ibrahimbegovi`, `46 40 150266emina@rubinmedical.se Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and $TNDM. Follow Tandem Diabetes Care on Facebook under www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on LinkedIn under www.linkedin.com/company/tandemdiabetes. You agree to notify Tandem immediately if someone else does not contact you improperly or offer to make or receive payments off-site. If you are aware of an infringement or possible violation of this circumvention agreement, please send a confidential report to Tandem: cick here to contact us. You can contact us by email: www.tandem.net/contact-us or by mail or mail under “This is the first pump distribution contract for the Diabetes Care tandem outside the United States and an important step forward for our international marketing strategy,” said Kim Blickenstaff, President and CEO of Tandem Diabetes Care. Rubin Medical`s proven success with insulin pumps in Sweden, Norway and Denmark and the proven support for patients and clinicians affected by diabetes make it an ideal distributor for us in these countries. If you wish to offer tandem tutoring services, you must read and accept these additional terms and conditions for tutors (“Tutor Conditions”) that are part of the Terms of Use in Tandem (www.tandem.net/termsofservice). These tutoring requirements apply to any account approved as a service tutor. If you do not fully accept these tutoring conditions, you are not allowed to teach about the service and you are not entitled to get money from Tandem or its members for a course and/or support service you offer on the service. DUBLIN – SAN DIEGO–July. 9, 2020– Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced today that they have entered into a non-exclusive cross-patent licensing agreement for certain diabetes-related technologies.

The cross-licensing of the other party`s patent portfolios allows both companies to focus on helping people with diabetes innovate in future products and services, while avoiding the distraction of potential legal differences. You can cancel your account at any time by using the “Delete Account” feature or by contacting us here: www.tandem.net/contact-us. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, addressing risks and uncertainties that could cause actual results to differ materially from the expected or projected results in the forward-looking statements. These forward-looking statements relate, among other things, to the distribution agreement between the company and Rubin Medical and the expected availability of the company`s products outside the United States. The company`s actual results may differ materially from those indicated in these forward-looking statements, due to numerous risks and uncertainties, including risks associated with the development of new products in general, including potential delays in the company`s product development programs; possible actions to be taken by regulators or government authorities, including the company`s potential not to achieve the “CE” mark for the company`s products if expected; The potential to terminate the company`s agreement with Rubin Medical; as well as other risks identified in Tandem`s latest Annual Report on Form 10-K or quarterly reports on Form 10-Q and other documents we submit to the Securities and Exchange Commission.

administrator

Обсуждение закрыто.